Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction (SVF) in the fingers of patients with systemic sclerosis.

vascular involvement

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 03 November 2014 - 08:29 AM

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction (SVF) in the fingers of patients with systemic sclerosis: an open-label phase I trial.

 

This study outlines the safety of the autologous SVF cells injection in the hands of patients with SSc and a significant improvement in hand disability and pain, Raynaud's phenomenon, finger oedema and quality of life was observed. PubMed, Ann Rheum Dis, 2014 Aug 11. (Also see: Vascular Involvement)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)